This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA6204A_M.jpg
The company’s shares have gained 42.2% in price over the past month, due primarily to its two new product launches. These products help protect consumers from COVID-19. Disinfectors nUVo Tower UVC air and nUVo Traveler are the two new products designed to destroy up to 99.9% of airborne pathogens in rooms 1,000 cubic feet in size.
However, the stock has declined 21.3% in price over the past year and 23.2% over the past nine months. EFOI’s inability to generate sufficient cash flows to fulfill its operational needs and its weak profitability have made investors question its prospects.
